KRYSTINA HADRA: Open Payments
NPI 1013353960 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 42 payments from 9 companies in 2025. Trend: 2023 $763 · 2024 $765 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $255 |
| Amgen Inc. | 14 | $164 |
| Exact Sciences Corporation | 4 | $113 |
| ABBVIE INC. | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Boston Scientific Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TRELEGY ELLIPTA, OTEZLA, The Cologuard Plus Collection Kit, Cologuard Collection Kit, VRAYLAR, REPATHA, GARDASIL 9, Kerendia.
Industry payments across FL — which companies pay providers there.
